Table 1 Correlation of the clinical characteristics with mutation status in Breast cancer cases
clinical characteristics | Total | BRCA1/2 Carriers | non Carriers | P-value |
|---|---|---|---|---|
Histological type | 0.8 | |||
 ductal carcinoma | 45 (91.8%) | 12 (92.3) | 33(91.6) | |
 lobular carcinoma | 3 (6.1%) | 1(7.6) | 2(5.5) | |
 Others | 1 (2.04%) | 0 | 1(2.7) | |
Tumor size | 0.7 | |||
 T1 | 14(28.5%) | 3(23.0%) | 11(30.5%) | |
 T2 | 22(44.8%) | 5(38.4%) | 17(47.2%) | |
 T3 | 11(22.4%) | 4(30.7%) | 7(19.4%) | |
 T4 | 2(4.08%) | 1(7.6%) | 1(2.7%) | |
SBR grade | 0.9 | |||
 I | 6(12.2%) | 2(15.3%) | 4(11.1%) | |
 II | 23(46.9%) | 6(46.1%) | 17(47.2%) | |
 III | 20(40.8%) | 5(38.4%) | 15(41.6%) | |
Molecular type | 0.03 | |||
 triple negative | 17 (34.6%) | 8 (61.5%) | 9 (25.0) | |
 luminal | 29 (59%) | 5 (38.4%) | 24(66.6) | |
 HER2+ | 3 (6.1%) | 0(0%) | 3(8.3) | |